July 09, 2025

Crisis Looms in Pathology Workforce

UK workforce census warns of mass retirements, rising burnout, and inadequate staffing.

The Pathologist

June 26, 2025

GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Crohn’s Disease

Glucagon-like peptide-1 (GLP-1) agonists, the increasingly popular class of drugs for treating diabetes and obesity, may have a role to play in promoting gut healing in patients with Crohn's disease, Mount Sinai researchers believe.

Mount Sinai New York

December 03, 2024

The Analytical Scientist Innovation Awards 2024: #6

Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer

The Pathologist

April 10, 2025

Roswell Park Reports Extraordinary Outcomes for Robot-Assisted Minimally Invasive Esophagectomy

Roswell Park Comprehensive Cancer Center achieved textbook outcomes for 90% of 150 consecutive robot-assisted, minimally invasive esophagectomies (RAMIE) performed from 2020-2024, as reported in a study in the Journal of Gastrointestinal Surgery. 

Roswell Park Comprehensive Cancer Center

February 05, 2025

Cancer, MASH, and Ensuring Health Equity

This report includes updates on screening for and treating cancer, raising public awareness for metabolic dysfunction-associated steatohepatitis (MASH), and ensuring health equity at Mount Sinai's Division of Liver Diseases.

Mount Sinai New York

November 20, 2024

UCI Health names new co-directors of the Digestive Health Institute

Dr. John G. Lee and Dr. Skandan Shanmugan will continue legacy of innovative healthcare and research.

UCI Health

October 31, 2024

Protein Identified as Potential New Target for Treating Cholangiocarcinoma

A Mount Sinai researcher discovered that many patients with cholangiocarcinoma exhibit a highly elevated expression of B7-H4, a transmembrane protein that inhibits T cell immunity. This could offer a new immunotherapy target for bile duct cancer, a rare disease where breakthroughs are equally rare.

Mount Sinai New York

August 05, 2024

Liver Surgery: Minimally Invasive Techniques Can Be an Option

At the majority of cancer centers, patients with liver cancer who are candidates for a major liver resection surgery will be given no options other than traditional open surgery. The experts at Miami Cancer Institute, part of Baptist Health, however, will often perform a minimally invasive approach such as laparoscopic or robotic-assisted surgery when surgery for liver cancer is recommended.

Baptist Health South Florida

January 25, 2024

Icahn School of Medicine at Mount Sinai Receives Helmsley Charitable Trust Grant for Crohn's Disease Research

The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million from The Leona M. and Harry B. Helmsley Charitable Trust to support an innovative research project aimed at understanding the early stages of Crohn’s disease before noticeable symptoms develop.

Mount Sinai New York